Nanjing Yixi Biotechnology
Latest round
- Series A
Last raised
- Aug 2025
Total raised
- $28M
Investors
- 1
About Nanjing Yixi Biotechnology
Established in 2019 and based in Suzhou, China, Nanjing Yixi Biotechnology is a synthetic biology company focusing on synthetic biology technology innovation and product development. The company has a production plant in Huangshan, Anhui Province, covering an area of 100 acres, with a current capacity of 300 tons/year. In January 2022, the company completed the construction of its R&D center in Suzhou and relocated to the Suzhou Industrial Park. The Company's products mainly include human milk oligosaccharides (HMOs), a synthetic bioproduct that blocks pathogens and promotes the growth of beneficial bacteria, which can be used in probiotics, dietary supplements and other food products. It also has Single Cell Protein (SCP) for feeding, a protein product that uses lignocellulose from straw as a raw material and is fermented by a combination of microorganisms to produce single-cell proteins that can be used as feed for pigs, chickens, cows, sheep and other livestock. The company generates revenue through deployment of its AI diagnostic systems, enterprise healthcare platforms, and service contracts with medical institutions.
Who invested in Nanjing Yixi Biotechnology
1 investor across 1 round
See all investors in Nanjing Yixi Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 20, 2025
Amount
$28M
Investors
Questions about Nanjing Yixi Biotechnology
Who invested in Nanjing Yixi Biotechnology?
Nanjing Yixi Biotechnology has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nanjing Yixi Biotechnology raised?
Nanjing Yixi Biotechnology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nanjing Yixi Biotechnology last raise money?
Nanjing Yixi Biotechnology's most recent round on record is a Series A, in Aug 2025.
What does Nanjing Yixi Biotechnology do?
Established in 2019 and based in Suzhou, China, Nanjing Yixi Biotechnology is a synthetic biology company focusing on synthetic biology technology innovation and product development.
Where is Nanjing Yixi Biotechnology headquartered?
Nanjing Yixi Biotechnology is headquartered in Nanjing, China.
Which VCs invest in companies like Nanjing Yixi Biotechnology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Nanjing Yixi Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Nanjing Yixi Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.